Freenome, Inc. Common stock Market Cap ($1.34 Billion)
Market Cap & Net Worth: Freenome, Inc. Common stock (FRNM)
Freenome, Inc. Common stock market cap. Freenome, Inc. Common stock (NASDAQ:FRNM) has a market capitalization of $1.34 Billion ($1.34 Billion) as of November 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #7388 globally and #2270 in its home market, demonstrating a -4.73% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Freenome, Inc. Common stock's stock price $12.48 by its total outstanding shares 107446814 (107.45 Million). Also see Freenome, Inc. Common stock operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Freenome, Inc. Common stock Market Cap History (2026–2026)
Freenome, Inc. Common stock market cap history from 2026 to 2026. Data shows growth from $1.34 Billion to $1.34 Billion (0.00% CAGR). Check latest Freenome, Inc. Common stock stock price today for real-time trading data and today's change.
Freenome, Inc. Common stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Freenome, Inc. Common stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore FRNM net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of FRNM by Market Capitalization
Companies near Freenome, Inc. Common stock in the global market cap rankings as of November 1, 2026. Also see Freenome, Inc. Common stock balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Freenome, Inc. Common stock by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #143 globally with a market cap of $164.04 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #480 globally with a market cap of $56.33 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #530 globally with a market cap of $51.40 Billion USD ( CN¥351.23 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $697.00 |
| #143 | Danaher Corporation | NYSE:DHR | $164.04 Billion | $232.23 |
| #480 | Natera Inc | NASDAQ:NTRA | $56.33 Billion | $414.30 |
| #530 | WuXi AppTec Co Ltd | SHG:603259 | $51.40 Billion | CN¥142.01 |
Market Capitalization of Freenome, Inc. Common stock (2026–2026)
Market capitalization of Freenome, Inc. Common stock from 2026 to today. Between 2026 and today, Freenome, Inc. Common stock's market cap moved from $1.34 Billion to $ 1.34 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.34 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Freenome, Inc. Common stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.34 Billion USD |
| MoneyControl | $1.34 Billion USD |
| MarketWatch | $1.34 Billion USD |
| marketcap.company | $1.34 Billion USD |
| Reuters | $1.34 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Freenome, Inc. Common stock
Freenome, Inc. operates as a biotechnology company in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer. It develops blood-based tests, including a test for colorectal cancer screening, as well as tests for multi-cancer and multi-disease det… Read more